+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07436845

Study of Emotional Health Impact on Outcomes in Adults with Advanced Liver Cancer Receiving Combined Hepatic Arterial Infusion Chemotherapy, Targeted Therapy, and Immunotherapy

Led by Nanfang Hospital, Southern Medical University · Updated on 2026-02-27

90

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how emotional health affects the outcomes of patients with advanced liver cancer BCLC stage B or C hepatocellular carcinoma who undergo hepatic arterial infusion chemotherapy combined with targeted immunotherapy. The study aims to understand if baseline emotional status influences treatment results, focusing on key measures like progression-free survival. This observational trial will enroll 90 patients divided into groups based on depressive symptoms using standardized scores. Patients will be assessed for their emotional status, quality of life, and immune-related blood markers before and during treatment. The study observes patients receiving hepatic arterial infusion chemotherapy combined with targeted and immunotherapy without altering their treatment. Emotional status is monitored at set time points to explore its role as a potentially modifiable factor affecting therapy effectiveness. Participants will be followed over time with evaluations including progression-free survival, objective response rate, disease control rate, overall survival, and safety. Emotional assessments and quality of life questionnaires will also be conducted regularly. The study lasts up to two years with ongoing monitoring to collect comprehensive data on clinical outcomes and emotional health, aiming to guide future integrated treatment approaches.

CONDITIONS

Brief Title

Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

Research Team

Y

Yuan Guosheng

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here